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Cervical Intramedullary Ganglioma
Harminder Singh MD, Ashwini Sharan MD, John K. Ratliff MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania 
A 48 year male presented to the ER with severe headaches which were episodic in nature and which 
had been present for several weeks. Patient had a history of traumatic head injury (TBI) several years 
prior. Otherwise, he was in good health with no significant past medical or surgical history.
On physical exam, patient was oriented x 3 with an intact cranial nerve exam. He had significant 
upper and lower extremity spasticity with mild hand intrinsic weakness. His motor exam was oth-
erwise unremarkable. His gait was very spastic. He had sustained lower extremity clonus, upgoing 
toes, and increased tone in the upper and lower extremities. His sensation was intact to light touch, 
pinprick, proprioception and temperature. 
What imaging studies would you order?
A CT scan of the brain was initially obtained secondary to the severity of the patients’ headaches and 
past history of TBI.
The head CT revealed an old lacunar infarct in the left basal ganglia. There was no intracerebral hem-
orrhage or extra axial collection. However, in the spinal cord at the level of C1, an 8 mm hypodensity 
was noted.
This prompted an MRI of the cervicomedullary junction.  An ovoid, 1.1 x 1.0 x 1.7 cm intramedullary 
lesion was seen expanding the cervical cord at the C1-2 level. It was hyperintense on T2-weighted 
images and hypointense on T1 weighted images, and demonstrated some mild curvilinear enhance-
ment within the lesion. 
What is your differential diagnosis?  Would you perform any further imaging?
These radiographic findings were consistent with a low grade tumor such as an astrocytoma. An 
ependymoma or cord metastasis were considered less likely. 
No evidence for primary malignancy was found on imaging of the chest, abdomen and pelvis.
Imaging of the entire neural-axis did not reveal any other lesions.
A CSF flow study on MRI was also performed to look at CSF flow dynamics, and evaluate for pos-
sible CSF outflow obstruction secondary to this lesion, which might have explained the patient’s 
headaches. Unobstructed CSF flow was identified anterior and posterior to the cervicomedullary 
junction at the foramen magnum and at the level of the intramedullary lesion at C1-C2. 
How would you treat this lesion? 
Observation and close neurological follow up
Perform a lumbar puncture for CSF cytology
Radiation and/or chemotherapy
Excisional biopsy 
Excisional biopsy followed by radiation and/or chemotherapy
This is a young, otherwise healthy male who is starting to develop neurological symptoms from 
a lesion with unknown pathology. Considering the rapid progression of his symptoms over a few 
weeks, we felt that it was necessary to expediently secure him a diagnosis via direct exploration of the 
lesion. Once the diagnosis was established, treatment tailored to his particular ailment could begin. 
While operative exploration of this lesion entails risk of significant morbidity, we felt the severity of 
his clinical findings and the progression of his deficit merited operative exploration.
A.
B.
C.
D.
E.
The diagnostic yield from CSF cytology is 
low (~26%)(3), although repeated sampling 
does increase the yield significantly. CSF flow 
cytometry also increases the diagnostic yield 
over CSF cytomorphology alone. (1) Newer 
techniques  like  fluorescence in situ hybridiza-
tion (FISH)  enhance the diagnostic yield for 
Figure 1
Pre-op axial non-contrast CT head showing 
hypodensity within the spinal cord
Figure 2
Pre-op sagittal T1-weighted MRI
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Case Report: Spine Tumor
the detection of malignancy on the first lumbar 
puncture in patients clinically suspected of 
having leptomeningeal metastases (LMM). (10) 
Radiographic imaging did not demonstrate any 
leptomeningeal spread in our patient.  In the 
absence of leptomeningeal spread, the chances 
of obtaining a diagnosis from CSF cytology are 
further diminished.
We decided to proceed with exploration and 
biopsy of the tumor. We planned to debulk  the 
tumor and to possibly resect the entirety of the 
tumor predicated upon the lesion’s  histopatho-
logical findings at the time of frozen section and 
intraoperative behavior.  Debulking the tumor 
would also alleviate the mass effect on the spinal 
cord, decrease tumor burden, and afford the 
patient a better chance at tumor control through 
adjuvant chemotherapy and radiation. 
How would you counsel the patient regarding 
the surgical risks?
The risks and benefits of surgery were explained 
at length. It was emphasized to the patient that 
there was a substantial risk of neurologic wors-
ening and a significant risk of paralysis second-
ary to the size of the tumor and its extremely 
sensitive location. The patient had previously 
suffered a significant head injury; hence, these 
discussions were also carried out with patient’s 
mother who acted as his guardian. While the 
patient was felt to be thoroughly consentable, 
the patient’s family was again counseled as to 
the severity of his diagnosis and the significant 
dangers of surgery.
What surgical approach would you 
use?  What intra-operative tools would 
help you in localization of this lesion?
We decided to approach this lesion through a 
posterior cervical approach. The patient was 
positioned prone using the Mayfield three-pin 
headholder. The patient’s neck was placed 
in gentle flexion to facilitate exposure of the 
occipitocervical junction. The posterior arch of 
C1, along with 50% of the top of the lamina of 
C2 was removed.  At the base of the occiput, we 
performed a limited suboccipital craniectomy 
using the Midas-Rex drill.  
The dura was opened next. Using intraopera-
tive ultrasound localization, we identified the 
patient’s large intramedullary tumor. We 
attempted to map the spinal cords’ midline 
using SSEPs; however, due to poor recordings 
and extensive lateral spread, we were unable to 
adequately map the posterior elements.  
We chose an entry point along the posterior 
elements.  The spinal cord was entered via 
bipolar and creating a sharp incision in the 
Figure 3
Pre-op sagittal T2-weighted MRI
Figure 4
Pre-op sagittal post-gadolinium MRI
Figure 5
Intraoperative ultrasound image, pre 
resection
Figure 6
Intraoperative ultrasound image, post 
resection
Figure 8
Post-operative sagittal MRI
Figure 7
Post-operative sagittal CT
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pia mater.  The cord was opened further using 
microscissors. Using blunt dissection, we gently 
reflected the pia-arachnoid. Using pial sutures, 
we gently retracted the spinal cord bilaterally. 
The patient’s intramedullary tumor was evident. 
Using blunt dissection, we gently developed 
a plane around the patient’s intramedullary 
tumor. A biopsy was obtained and sent for 
frozen section. Frozen section returned a low-
grade astrocytoma.  
We continued our resection, removing as much 
of the tumor as we felt safe. We periodically 
checked motor evoked potentials during our 
decompression. After we had completed our 
decompression, we used the ultrasound to 
confirm that no further gross elements of 
tumor were evident. There was a gliotic shell, 
which was evident around the spinal cord; 
however, based on ultrasound localization, the 
main portion of the patient’s tumor had been 
successfully extirpated.
There was some mild loss of hand intrinsic 
motor evoked potentials during the procedure; 
however, this was less than 50% loss and was 
not felt to be severe.  After hemostasis had been 
achieved, the wound was thoroughly irrigated. 
The dura was closed using #6-0 Gore-Tex 
sutures.
Postoperatively, the patient recovered well. His 
motor and sensory exam remained stable.  
Permanent section was consistent with that of 
ganglioglioma. 
Ganglioglioma was first described by Courville in 
1930 as a central nervous system neoplasm con-
taining both astrocytic and neuronal components.  
Gangliogliomas are firm grayish tumors that 
may have cystic components. On light micros-
copy, atypical dysplastic neurons, astrocytes, and 
fibrovascular stroma are observed. Infrequently, 
anaplastic degeneration occurs and involves 
the astrocytic component. Neoplastic ganglion 
cells are large and mature and reveal intense 
immunoreactivity with synaptophysin, show 
expression of the stem cell epitope CD34, and 
are often binucleated.  
Most gangliogliomas are observed in the brain. 
Temporal lobes and cerebellar hemispheres are 
the most common locations. Rarely, they may 
also develop in the spinal cord. Only 1% of 
intramedullary spinal neoplasms are histologi-
cally gangliogliomas. 
Now that diagnosis has been established, 
would you recommend any further treatment 
for this patient?
Radical surgery for intraspinal tumors can 
achieve long tumor-free survival without 
requiring adjuvant therapy.(4)  In cases of low-
grade tumor, radical excision is associated with 
minimal morbidity and an excellent long-term 
prognosis when carried out before significant 
disability occurs.(2)  Gangliogliomas are gener-
ally classified as WHO grade 1 lesions; however, 
malignant transformation can occur.
In one study, the 5-year actuarial survival 
rates for cerebral hemisphere, spinal cord, and 
brain-stem gangliogliomas were 93%, 84%, 
and 73%, respectively (p = 0.7). The event-free 
survival rate at 5 years was 95% for cerebral 
hemisphere gangliogliomas and 36% for spinal 
cord gangliogliomas (p < 0.05); for brain-stem 
gangliogliomas the event-free survival rate at 3 
years was 53% (p < 0.05). Multivariate analysis 
(Cox linear regression) revealed tumor location 
to be the only variable predictive of outcome, 
with spinal cord and brain-stem gangliogliomas 
having a 3.5- and 5-fold increased relative risk of 
recurrence, respectively, compared to cerebral 
hemisphere gangliogliomas. Histological grade 
was not predictive of outcome, although in each 
location there was a trend for higher-grade 
tumors to have a shorter time to recurrence.(6)
It is concluded that radical surgery leads to long-
term survival of patients with gangliogliomas, 
regardless of location, and adjuvant therapy 
can probably be reserved for special cases (e.g. 
tumors with a high KI 67 index). (4, 5, 7-9) 
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Figure 10
Chromogranin staining of atypical ganglion 
cells in background of neoplastic glial cells
Figure 9
Atypical ganglion cells including binucle-
ated ganglion cell
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